Daré Bioscience, Inc. (DARE)

Daré Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Cash & Equivalents	12.62	18.52	24.71	23.08	5.04	10.33	15.7	11.23	16.41	3.63	10.48	13.89	13.33	19.83	34.67	40.39	32.07	39.32	51.67	45.57
Cash & Short-Term Investments	12.62	18.52	24.71	23.08	5.04	10.33	15.7	11.23	16.41	3.63	10.48	13.89	13.33	19.83	34.67	40.39	32.07	39.32	51.67	45.57
Cash Growth (YoY)	150.60%	79.28%	57.42%	105.43%	-69.33%	184.53%	49.85%	-19.16%	23.15%	-81.69%	-69.78%	-65.60%	-58.44%	-49.56%	-32.91%	-11.37%	251.97%	413.26%	1006.64%	745.56%
Accounts Receivable	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10	-	-	-
Other Receivables	0.06	0.29	0.57	0.37	0.19	0.11	0.23	0.52	0.9	1.39	0.95	1.13	0.57	2.4	1.7	2.29	2.14	1.73	1.15	0.16
Receivables	0.06	0.29	0.57	0.37	0.19	0.11	0.23	0.52	0.9	1.39	0.95	1.13	0.57	2.4	1.7	2.29	12.14	1.73	1.15	0.16
Prepaid Expenses	2.78	1.77	1.39	1.51	1.38	1.39	2.52	3.19	3.51	4.81	6.12	6.58	8.07	7.08	6.67	6.89	5.9	6.77	2.48	2.52
Other Current Assets	1.24	1.08	0.39	0.05	-	-	-	-	-	0.15	-	0.83	0.27	0.2	-	-	-	-	-	-
Total Current Assets	16.69	21.66	27.06	25	6.6	11.82	18.45	14.95	20.83	9.98	17.54	22.44	22.24	29.51	43.04	49.57	50.11	47.82	55.3	48.24
Property, Plant & Equipment	3.13	3.73	4.4	4.73	5.31	5.72	2.54	2.03	1.77	1.61	1.98	0.24	0.32	0.42	0.52	0.62	0.02	0.03	0.24	0.34
Long-Term Deferred Charges	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.14	-
Other Long-Term Assets	2.55	2.44	1.01	1.02	1.07	1.08	1.11	1.08	1.01	1.42	1.76	2.38	0.64	0.43	0.26	0.19	1.26	1.34	0.13	0.23
Total Assets	22.37	27.83	32.47	30.75	12.98	18.62	22.1	18.06	23.61	13.01	21.28	25.05	23.21	30.37	43.83	50.38	51.39	49.19	55.81	48.81

Liabilities

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Accounts Payable	0.76	1.23	1.2	1.84	1.76	1.88	1.46	1.05	1.91	4.04	3.39	4.99	6.54	2.7	2.03	3.48	1.11	2.83	2.1	0.61
Accrued Expenses	0.45	0.53	0.73	2.32	2.52	1.77	3.04	1.85	1.25	1.38	2.89	5.29	4.19	5.48	10.89	4.14	6.35	3.54	3.14	3.53
Current Portion of Long-Term Debt	0.01	0.01	0.01	0.01	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Portion of Leases	0.74	1.2	2.1	2.48	2.42	2.32	0.55	0.51	0.49	0.47	0.47	0.19	0.27	0.34	0.4	0.39	0.32	0.29	0.27	0.37
Current Unearned Revenue	14.95	18.15	19.65	14.56	12.33	15.12	16.56	9.75	10.94	11.84	13.74	15.87	13.69	15.83	18.3	14.84	8.75	9.73	10.54	11.16
Other Current Liabilities	-	-	-	-	0.19	0.09	-	-	-	-	-	-	-	-	-	-	-	-	-	0.25
Total Current Liabilities	16.92	21.12	23.69	21.22	19.22	21.19	21.61	13.16	14.59	17.72	20.48	26.34	24.7	24.34	31.62	22.84	16.54	16.39	16.05	15.91
Long-Term Debt	5.73	5.56	5.39	5.22	-	-	4.75	-	4.31	-	-	-	-	-	-	-	-	-	-	-
Long-Term Leases	0.27	0.42	0.56	0.45	0.61	1.25	0.75	0.9	1.04	1.17	0.94	-	0.02	0.06	0.09	0.19	0.82	0.91	-	0.02
Long-Term Unearned Revenue	-	-	-	1	1	1	1	1	1	5.12	1	1	1.21	1	1	1	1	1	1	1
Other Long-Term Liabilities	-	-	-	-	4.88	4.74	-	4.49	-	-	3.91	-	-	-	-	-	-	-	-	-
Total Liabilities	22.93	27.09	29.63	27.89	25.71	28.18	28.11	19.54	20.93	24.01	26.33	27.34	25.93	25.4	32.71	24.03	18.36	18.31	17.05	16.92

Shareholders' Equity

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Common Stock	0	0	0	0	0	0	0	0	0	0.01	0	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	194.48	192.8	191.95	190.5	171.35	170.52	169.71	168.66	168.14	167.38	166.55	164.3	155.56	154.45	152.53	152	151.44	149.56	149.03	132.64
Retained Earnings	-194.67	-191.69	-188.69	-187.25	-183.68	-179.67	-175.29	-169.78	-165.08	-177.99	-171.24	-166.18	-157.88	-149.12	-141.07	-125.13	-118.11	-118.53	-110.13	-100.58
Comprehensive Income & Other	-0.37	-0.38	-0.42	-0.4	-0.4	-0.42	-0.43	-0.36	-0.39	-0.4	-0.36	-0.42	-0.4	-0.37	-0.35	-0.53	-0.3	-0.16	-0.15	-0.17
Total Common Equity	-0.56	0.73	2.84	2.86	-12.73	-9.56	-6.01	-1.48	2.67	-11	-5.05	-2.29	-2.72	4.97	11.11	26.34	33.03	30.88	38.75	31.89
Shareholders' Equity	-0.56	0.73	2.84	2.86	-12.73	-9.56	-6.01	-1.48	2.67	-11	-5.05	-2.29	-2.72	4.97	11.11	26.34	33.03	30.88	38.75	31.89
Total Liabilities & Equity	22.37	27.83	32.47	30.75	12.98	18.62	22.1	18.06	23.61	13.01	21.28	25.05	23.21	30.37	43.83	50.38	51.39	49.19	55.81	48.81

Additional Metrics

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Total Debt	6.76	7.18	8.05	8.16	3.03	3.57	6.05	1.4	5.83	1.64	1.4	0.19	0.3	0.39	0.49	0.58	1.15	1.21	0.27	0.38
Net Cash (Debt)	5.85	11.34	16.66	14.91	2	6.76	9.65	9.83	10.58	1.99	9.07	13.7	13.03	19.44	34.18	39.81	30.92	38.11	51.4	45.19
Net Cash Growth (YoY)	192.36%	67.77%	72.69%	51.71%	-81.08%	239.80%	6.33%	-28.26%	-18.81%	-89.77%	-73.46%	-65.58%	-57.85%	-49.00%	-33.51%	-11.91%	258.76%	439.49%	1213.79%	897.61%
Net Cash Per Share	0.41	0.90	1.49	1.55	0.23	0.79	1.14	1.18	1.34	0.26	1.25	1.92	1.82	2.75	4.85	6.19	4.65	6.44	10.09	9.40
Filing Date Shares Outstanding	15.29	14.98	14.56	14.29	13.48	8.85	8.85	8.7	8.55	8.42	8.38	8.21	7.32	7.19	7.18	7.07	7.07	7.06	7	6.38
Total Common Shares Outstanding	15.17	14.56	14.5	13.93	9.03	8.85	8.7	8.55	8.55	8.38	8.33	8.19	7.22	7.18	7.07	7.07	7.07	7	7	6.38
Working Capital	-0.24	0.54	3.38	3.79	-12.62	-9.37	-3.17	1.79	6.24	-7.74	-2.94	-3.91	-2.46	5.17	11.41	26.73	33.58	31.42	39.24	32.34
Book Value Per Share	-0.04	0.05	0.20	0.21	-1.41	-1.08	-0.69	-0.17	0.31	-1.31	-0.61	-0.28	-0.38	0.69	1.57	3.73	4.67	4.41	5.54	5.00
Tangible Book Value	-0.56	0.73	2.84	2.86	-12.73	-9.56	-6.01	-1.48	2.67	-11	-5.05	-2.29	-2.72	4.97	11.11	26.34	33.03	30.88	38.75	31.89
Tangible Book Value Per Share	-0.04	0.05	0.20	0.21	-1.41	-1.08	-0.69	-0.17	0.31	-1.31	-0.61	-0.28	-0.38	0.69	1.57	3.73	4.67	4.41	5.54	5.00
Machinery	-	-	1.86	-	-	-	0.24	-	-	-	0.16	-	-	-	-	-	-	-	-	-
Construction In Progress	-	-	-	-	-	-	1.23	-	-	-	0.6	-	-	-	-	-	-	-	-	-
Leasehold Improvements	-	-	0.04	-	-	-	0.04	-	-	-	0.04	-	-	-	-	-	-	-	-	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 15, 2026

Data Sources Report a data error